T

TECH

Nasdaq

BIO-TECHNE Corp

Latest disclosureSeptember 30, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 1 sales

Price by TradingView

Insider transactions 98

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Sale disclosed

Amy E. Herr

Director

Common Stock

Reported value: $320.39K
Reported price: $48.28 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
Director	Common StockSale	6,636$48.28 / share	$320.39K	May 8Filed May 12 · 4d later	SEC filing

Congress transactions 7

All Congress filings

Sale disclosed

Bio-Techne Corp - Common Stock (TECH) · Stock

The filing reports a sale for a dependent.

April McClain Delaney official portrait

April McClain DelaneyReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: April 8, 2026

Partial sale disclosed

Bio-Techne Corp - Common Stock (TECH) · Stock

The filing reports a partial sale for a dependent.

April McClain Delaney official portrait

April McClain DelaneyReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 26, 2026

Partial sale disclosed

Bio-Techne Corp - Common Stock (TECH) · Stock

The filing reports a partial sale for a dependent.

April McClain Delaney official portrait

April McClain DelaneyReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 24, 2026

Partial sale disclosed

Bio-Techne Corp - Common Stock (TECH) · Stock

The filing reports a partial sale for a dependent.

April McClain Delaney official portrait

April McClain DelaneyReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: January 28, 2026

Purchase disclosed

Bio-Techne Corp - Common Stock (TECH) · Stock

The filing reports a purchase for a dependent.

April McClain Delaney official portrait

April McClain DelaneyReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 5, 2025

Purchase disclosed

Bio-Techne Corp - Common Stock (TECH) · Stock

The filing reports a purchase for a dependent.

April McClain Delaney official portrait

April McClain DelaneyReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 2, 2025

Purchase disclosed

Bio-Techne Corp - Common Stock (TECH) · Stock

The filing reports a purchase for a dependent.

April McClain Delaney official portrait

April McClain DelaneyReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 22, 2025

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000842023
Latest public acceptance: Sep 30, 2026, 08:13 PM UTC
Score calculated: Oct 8, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.